Literature DB >> 22458905

Implications of the International Society of Urological Pathology modified Gleason grading system.

Lars Egevad1, Roberta Mazzucchelli, Rodolfo Montironi.   

Abstract

CONTEXT: Histologic grading is the clinically most useful tissue-based predictor of prognosis for prostate cancer. Over the years, there has been a gradual shift in how the Gleason grading is applied in practice, with a general trend toward upgrading. A consensus conference was organized in 2005 by the International Society of Urological Pathology (ISUP) for standardizing both the perception of histologic patterns and how the grade information is compiled and reported.
OBJECTIVE: To review the implications of the ISUP modified Gleason grading system. DATA SOURCES: Personal experience and review of the current literature.
CONCLUSIONS: The recommendations regarding pattern interpretation and reporting are summarized. The practical consequences of the ISUP modification of the Gleason grading are reported. The prognostic importance of the Gleason score, its reproducibility, and its preoperative assessment are discussed. Subsequent proposals for slight modifications to the ISUP grading system are described.

Entities:  

Mesh:

Year:  2012        PMID: 22458905     DOI: 10.5858/arpa.2011-0495-RA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  21 in total

1.  A Novel System for Estimating Residual Disease and Pathologic Response to Neoadjuvant Treatment of Prostate Cancer.

Authors:  Claire Murphy; Lawrence True; Funda Vakar-Lopez; Jing Xia; Roman Gulati; Bruce Montgomery; Maria Tretiakova
Journal:  Prostate       Date:  2016-06-08       Impact factor: 4.104

2.  Predicting Prostate Cancer Progression as a Function of ETS-related Gene Status, Race, and Obesity in a Longitudinal Patient Cohort.

Authors:  Jennifer Cullen; Denise Young; Yongmei Chen; Michael Degon; James Farrell; Jason Sedarsky; Wagner Baptiste; Philip Rosen; Vladimir Tolstikov; Michael Kiebish; Jacob Kagan; Sudhir Srivastava; Huai-Ching Kuo; Joel T Moncur; Inger L Rosner; Niven Narain; Viatcheslav Akmaev; Gyorgy Petrovics; Albert Dobi; David G McLeod; Shiv Srivastava; Isabell A Sesterhenn
Journal:  Eur Urol Focus       Date:  2017-03-11

3.  [Documentation quality of histopathology reports of prostate needle biopsies: a snapshot].

Authors:  S Biesterfeld
Journal:  Urologe A       Date:  2014-11       Impact factor: 0.639

4.  Collagenous micronodules in prostate cancer revisited: are they solely associated with Gleason pattern 3 adenocarcinomas?

Authors:  Mi J Kim; Mukul K Divatia; Jeong H Lee; Steven Shen; Brian J Miles; Jun H Hwang; Alberto G Ayala; Jae Y Ro
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

5.  The Significance of Accurate Determination of Gleason Score for Therapeutic Options and Prognosis of Prostate Cancer.

Authors:  Burkhard Helpap; Daniel Ringli; Jens Tonhauser; Immanuel Poser; Jürgen Breul; Heidrun Gevensleben; Hans-Helge Seifert
Journal:  Pathol Oncol Res       Date:  2015-11-12       Impact factor: 3.201

Review 6.  The evolving Gleason grading system.

Authors:  Ni Chen; Qiao Zhou
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

7.  Impact of real-time, dose-escalated permanent seed implant brachytherapy in intermediate-risk prostate cancer.

Authors:  O Pons-Llanas; E Collado-Ballesteros; S Roldan-Ortega; A Conde-Moreno; F Celada-Alvarez; F Martínez-Arcelus; M J Pérez-Calatayud; V Carmona-Meseguer; J Gimeno-Olmos; V Forner-Ferrer; A Tormo-Micó; J Perez-Calatayud; J López-Torrecilla
Journal:  Rep Pract Oncol Radiother       Date:  2020-05-08

8.  Prediction of pathological and oncological outcomes based on extended prostate biopsy results in patients with prostate cancer receiving radical prostatectomy: a single institution study.

Authors:  Fumio Ishizaki; Noboru Hara; Hiroshi Koike; Makoto Kawaguchi; Akira Tadokoro; Itsuhiro Takizawa; Tsutomu Nishiyama; Kota Takahashi; Rudolf Hohenfellner
Journal:  Diagn Pathol       Date:  2012-06-14       Impact factor: 2.644

9.  Importance and determinants of Gleason score undergrading on biopsy sample of prostate cancer in a population-based study.

Authors:  Elisabetta Rapiti; Robin Schaffar; Christophe Iselin; Raymond Miralbell; Marie-Françoise Pelte; Damien Weber; Roberto Zanetti; Isabelle Neyroud-Caspar; Christine Bouchardy
Journal:  BMC Urol       Date:  2013-04-11       Impact factor: 2.264

10.  Outcomes and trends of prostate biopsy for prostate cancer in Chinese men from 2003 to 2011.

Authors:  Rong Na; Haowen Jiang; Seong-Tae Kim; Yishuo Wu; Shijun Tong; Limin Zhang; Jianfeng Xu; Yinghao Sun; Qiang Ding
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.